Novo Nordisk

Kate Mulroney is a transformative leader in the pharma industry, currently serving as senior director at Novo Nordisk. Known for her strategic foresight and innovative approach, Kate is dedicated to driving the use of advanced analytics and AI to improve healthcare outcomes and optimize business processes.

A Visionary at the Crossroads of Tech and Healthcare

Kate Mulroney’s career is a testament to her ability to blend cutting-edge technology with strategic business acumen. Over the years, she has successfully driven innovative analytical and technical solutions. Her career began with roles in sales automation and commercial data warehousing at BristolMyers Squibb and Bracco Diagnostics. Later, she made a significant impact through her consulting work with major pharmaceutical firms.

Kate’s leadership in business analysis, data science, and IT strategy has been demonstrated in her senior roles at Merck & Company, where she was integral in shaping sales force performance and strategic targeting.

At Novo Nordisk, she leads the charge in harnessing AI and advanced analytics to streamline drug development processes, enhance clinical outcomes and optimize internal operations. Under her leadership, AI has become a central tool in transforming business strategies, especially in R&D, where her initiatives have accelerated the pace of innovation and reduced time-to-market for critical therapies.

“AI has become a central tool in transforming business strategies, especially in R&D”

Driving Innovation with AI in Pharma

Mulroney’s leadership is characterized by her ability to unite multidisciplinary teams, including data scientists, clinicians and executives, around a shared vision of technological advancement. This collaborative approach has been key to successfully deploying AI and analytics solutions that have transformed Novo Nordisk’s operations and business outcomes.

Her work goes beyond just applying AI. She ensures that AI is integrated into the broader business strategy, helping the company deliver on its mission to improve patient lives.

A lifelong learner, Mulroney continually seeks to expand her knowledge and expertise in data science and AI. She is recognized as a thought leader in the field, sharing her insights and experiences at industry events and engaging in mentorship to cultivate the next generation of leaders in advanced analytics.

Kate Mulroney remains at the forefront of transforming the future of healthcare through the intelligent application of data and technology, with a focus on improving the efficiency of drug development and patient care.